Ara
Toplam kayıt 3, listelenen: 1-3
Is there any advantage of treating partners in helicobacter pylori eradication?
(Hindawi Ltd, 2015)
Aim. We designed this trial to find answers to the following questions. (1) Does the success rate decrease in a country where HP prevalence is high? (2) Can we provide benefit by simultaneously treating the partners of ...
Comparison of levofloxacin- and moxifloxacin-based triple therapies with standard treatment in eradication of helicobacter pylori as first-line therapy
(Karger, 2014)
Aim: It is recommended that treatments that include clarithromycin should be avoided in eradication of Helicobacter pylori (HP) in cases where clarithromycin resistance is higher than 20%. We aimed to compare levofloxacin-and ...
Comparison of standard triple therapy, sequential therapy and moxifloxacin-based triple therapy for Helicobacter pylori infection: Patients' compliance and bacterial eradication rates
(Wiley, 2014)
ObjectiveTo compare the patients' compliance with and the efficacy of existing treatments for Helicobacter pylori eradication, including moxifloxacin-based triple therapy, sequential treatment and the standard treatment. ...
